Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 16;12(8):e057361.
doi: 10.1136/bmjopen-2021-057361.

Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study

Affiliations

Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study

Eberechi Nwogu-Onyemkpa et al. BMJ Open. .

Abstract

Objective: Sickle cell disease (SCD) is a highly morbid condition notable for recurrent hospitalisations due to vaso-occlusive crises and complications of end organ damage. Little is known about the use of inpatient palliative care services in adult patients with SCD. This study aims to evaluate inpatient palliative care use during SCD-related hospitalisations overall and during terminal hospitalisations. We hypothesise that use of palliative care is low in SCD hospitalisations.

Design: A retrospective cross-sectional study using data from the National Inpatient Sample from 2008 to 2017 was conducted.

Setting: US hospitals from 47 states and the District of Columbia.

Participants: Patients >18 years old hospitalised with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) or ICD-10-CM diagnosis of SCD were included.

Primary and secondary outcome measures: Palliative care service use (documented by ICD-9-CM and ICD-10-CM diagnosis codes V66.7 and Z51.5).

Results: 987 555 SCD-related hospitalisations were identified, of which 4442 (0.45%) received palliative care service. Palliative care service use increased at a rate of 9.2% per year (95% CI 5.6 to 12.9). NH-black and Hispanic patients were 33% and 53% less likely to have palliative care services compared with NH-white patients (OR 0.67; 95% CI 0.45 to 0.99 and OR 0.47; 95% CI 0.26 to 0.84). Female patients (OR 0.40; 95% CI 0.21 to 0.76), Medicaid use (OR 0.40; 95% CI 0.21 to 0.78), rural (OR 0.47; 95% CI 0.28 to 0.79) and urban non-teaching hospitals (OR 0.61; 95% CI 0.47 to 0.80) each had a lower likelihood of palliative care services use.

Conclusion: Use of palliative care during SCD-related hospitalisations is increasing but remains low. Disparities associated with race and gender exist for use of palliative care services during SCD-related hospitalisation. Further studies are needed to guide evidence-based palliative care interventions for more comprehensive and equitable care of adult patients with SCD.

Keywords: adult palliative care; anaemia; haematology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Temporal trends in the rates of palliative care use 2008–2017. AAPC, average annual percentage change; SCD, sickle cell disease. ‘*’ indicates statistically significant findings.

Similar articles

Cited by

References

    1. Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med 2017;377:1561–73. 10.1056/NEJMra1510865 - DOI - PubMed
    1. Brousseau DC, Panepinto JA, Nimmer M, et al. . The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol 2010;85:77–8. 10.1002/ajh.21570 - DOI - PubMed
    1. Platt OS, Brambilla DJ, Rosse WF, et al. . Mortality in sickle cell disease. life expectancy and risk factors for early death. N Engl J Med 1994;330:1639–44. 10.1056/NEJM199406093302303 - DOI - PubMed
    1. Saulsberry AC, Porter JS, Hankins JS. A program of transition to adult care for sickle cell disease. Hematology Am Soc Hematol Educ Program 2019;2019:496–504. 10.1182/hematology.2019000054 - DOI - PMC - PubMed
    1. Charache S, Terrin ML, Moore RD, et al. . Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med 1995;332:1317–22. 10.1056/NEJM199505183322001 - DOI - PubMed

Publication types